Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Atropine for Myopia Control in Children (AIM)
NCT03865160Phase 3Active, not recruiting
- Sponsor
- University Eye Hospital Freiburg
- Start
- Oct 2021
- Primary completion
- Nov 2025
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of NVK002 in myopia, sponsored by University Eye Hospital Freiburg. Started Oct 2021; status: active, not recruiting.
02
Drugs
NVK002
03
Conditions
myopia
Beyond the preview
Go deeper on NCT03865160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03865160.